| __timestamp | Merck & Co., Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 242549000 |
| Thursday, January 1, 2015 | 6704000000 | 245098000 |
| Friday, January 1, 2016 | 7194000000 | 147600000 |
| Sunday, January 1, 2017 | 9982000000 | 264600000 |
| Monday, January 1, 2018 | 9752000000 | 357900000 |
| Tuesday, January 1, 2019 | 9872000000 | 1182600000 |
| Wednesday, January 1, 2020 | 13397000000 | 357700000 |
| Friday, January 1, 2021 | 12245000000 | 540100000 |
| Saturday, January 1, 2022 | 13548000000 | 322900000 |
| Sunday, January 1, 2023 | 30531000000 | 408000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, innovation is the lifeblood that drives progress. Merck & Co., Inc. and United Therapeutics Corporation are two titans in this field, each with a unique approach to research and development (R&D) investment. Over the past decade, Merck has consistently outpaced United Therapeutics in R&D spending, with a staggering 4,200% more investment in 2023 alone. This trend highlights Merck's commitment to pioneering new treatments and therapies. From 2014 to 2023, Merck's R&D expenses surged by over 300%, reflecting its aggressive strategy to maintain a competitive edge. In contrast, United Therapeutics has shown a more modest increase, focusing on niche innovations. This disparity underscores the diverse strategies within the pharmaceutical sector, where both companies aim to transform healthcare, albeit on different scales.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Insights: How Merck & Co., Inc. and Zoetis Inc. Allocate Funds
Merck & Co., Inc. vs Biogen Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Merck & Co., Inc. and Incyte Corporation
R&D Spending Showdown: Merck & Co., Inc. vs ACADIA Pharmaceuticals Inc.
Merck & Co., Inc. vs Travere Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Merck & Co., Inc. vs Evotec SE
Merck & Co., Inc. or MiMedx Group, Inc.: Who Invests More in Innovation?
Research and Development Investment: Biogen Inc. vs United Therapeutics Corporation
Comparing Innovation Spending: United Therapeutics Corporation and Neurocrine Biosciences, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Opthea Limited
Research and Development Expenses Breakdown: United Therapeutics Corporation vs CRISPR Therapeutics AG